Rheumatoid arthritis: From bench to bedside

Rheumatic Disease Clinics of North America

Volumn 27, Issue 2, 2001, Pages 373-387

  McInnes, Iain B ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTIRHEUMATIC AGENT; CYCLOSPORIN A; CYTOKINE; LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTHROSCOPY; BIOPSY; CELL CONTACT; CELL INTERACTION; CLINICAL TRIAL; HUMAN; IMMUNOHISTOLOGY; MACROPHAGE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

EID: 0034997539     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70207-6     Document Type: Article

References (76)

1. T. Aarvak M. Chabaud P. Miossec IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells J Immunol 162 1999 1246
2. W.P. Arend J.M. Dayer Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis Arthritis Rheum 38 1995 151
3. F.C. Arnett S.M. Edworthy D.A. Bloch The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315
4. K. Asadullah W. Sterry K. Stephanek IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach J Clin Invest 101 1998 783
5. S.C. Ballara E.M. Paleolog P.C. Taylor Elevated serum VEGF in early arthritis Arthritis Rheum 42 1999 S244
6. J. Bondeson B. Foxwell F. Brennan Defining therapeutic targets by using adenovirus: Blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators Proc Natl Acad Sci USA 96 1999 5668
7. F.M. Brennan D. Chantry A. Jackson Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis Lancet 2 1989 244
8. F.M. Brennan K.A. Browne P.A. Green Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy Br J Rheumatol 36 1997 643
9. B. Bresnihan J.M. Alvaro-Gracia M. Cobby Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthritis Rheum 41 1998 2196
10. D. Burger R. Rezzonico J.M. Li Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines Arthritis Rheum 41 1998 1748
11. P. Charles M.J. Elliott D. Davis Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis J Immunol 163 1999 1521
12. E.H. Choy C. Pitzalis A. Cauli Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens Arthritis Rheum 39 1996 52
13. C.L. Danning G.G. Illei C. Hitchon Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis Arthritis Rheum 43 2000 1244
14. J.M. Dayer D. Burger Cytokine and direct cell-contact in synovitis: Relevance to therapeutic intervention Arthritis Research 1 1999 17
15. M.J. Elliott R.N. Maini M. Feldmann Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105
16. M. Feldmann F.M. Brennan R.N. Maini Rheumatoid arthritis Cell 85 1996 307
17. M. Feldmann F.M. Brennan R.N. Maini Role of cytokines in rheumatoid arthritis Annu Rev Immunol 14 1996 397
18. D.A. Fox The role of T cells in the immunopathogenesis of rheumatoid arthritis Arthritis Rheum 40 1997 598
19. J.K. Franz S.A. Kolb K.M. Hummel Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis Eur J Immunol 28 1998 2661
20. S. Ghosh M.J. May E.B. Kopp NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses Annu Rev Immunol 16 1998 225
21. R. Goldbach-Mansky J. Lee A. McCoy Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset Arthritis Research 2 2000 236
22. J.A. Gracie R.J. Forsey W.L. Chan A proinflammatory role for IL-18 in rheumatoid arthritis J Clin Invest 104 1999 1393
23. F. Iannone V.M. Corrigall G.H. Kingsley Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis Eur J Immunol 24 1994 2706
24. P.D. Katsikis C.Q. Chu F.M. Brennan Immunoregulatory role of interleukin 10 in rheumatoid arthritis J Exp Med 179 1994 1517
25. A.F. Kavanaugh H. Schulze-Koops L.S. Davis Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody Arthritis Rheum 40 1997 849
26. J. Keffer L. Probert H. Cazlaris Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis EMBO J 10 1991 4025
27. M. Kitagawa H. Mitsui H. Nakamura Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals Arthritis Rheum 42 1999 1917
28. P.A. Klimiuk H. Yang J.J. Goronzy Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent Clin Immunol 90 1999 65
29. A.E. Koch Angiogenesis: Implications for rheumatoid arthritis Arthritis Rheum 41 1998 951
30. A.S. Korganow H. Ji S. Mangialaio From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins Immunity 10 1999 451
31. M.C. Kraan H. Versendaal M. Jonker Asymptomatic synovitis precedes clinically manifest arthritis Arthritis Rheum 41 1998 1481
32. M.C. Kraan J.J. Haringman W.J. Post Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis Rheumatology 38 1999 1074
33. P. Loetscher M. Uguccioni L. Bordoli CCR5 is characteristic of Th1 lymphocytes Nature 391 1998 344
34. R.N. Maini P.C. Taylor Anti-cytokine therapy for rheumatoid arthritis Annu Rev Med 51 2000 207
35. R.N. Maini H. Paulus F.C. Breedveld rHuIL-10 in subjects with active rheumatoid arthritis (RA): A phase I and cytokine response study Arthritis Rheum 40 suppl 1997 S224
36. D. McGonagle W. Gibbon P. Emery Classification of inflammatory arthritis by enthesitis Lancet 352 1998 1137
37. I.B. McInnes B.P. Leung Innate response cytokines in inflammatory synovitis: A role for interleukin-15 Current Directions in Autoimmunity 3 2001 200
38. I.B. McInnes B.P. Leung F.Y. Liew Cell-cell interactions in synovitis: Interactions between T lymphocytes and synovial cells Arthritis Research 2 2000 374
39. I.B. McInnes B.P. Leung R.D. Sturrock Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis Nat Med 3 1997 189
40. I.B. McInnes J.A. Gracie B.P. Leung Interleukin 18: A pleiotropic participant in chronic inflammation Immunol Today 21 2000 312
41. McInnes I.B. al-Mughales J. M. Field The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis Nat Med 2 1996 175
42. A.V. Miagkov D.V. Kovalenko C.E. Brown NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint Proc Natl Acad Sci USA 95 1998 13859
43. P. Miossec Are T cells in rheumatoid synovium aggressors or bystanders? Curr Opin Rheumatol 12 2000 181
44. L.W. Moreland S.W. Baumgartner M.H. Schiff Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 1997 141
45. J.R. O'Dell Anticytokine therapy—a new era in the treatment of rheumatoid arthritis? N Engl J Med 340 1999 310
46. N. Oppenheimer-Marks R.I. Brezinschek M. Mohamadzadeh Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo J Clin Invest 101 1998 1261
47. E.M. Paleolog M. Hunt M.J. Elliott Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis Arthritis Rheum 39 1996 1082
48. V.J. Palombella E.M. Conner J.W. Fuseler Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis Proc Natl Acad Sci USA 95 1998 15671
49. G.S. Panayi T-cell-dependent pathways in rheumatoid arthritis Curr Opin Rheumatol 9 1997 236
50. T. Pincus J.R. O'Dell J.M. Kremer Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: A preventive strategy Ann Intern Med 131 1999 768
51. S. Qin J.B. Rottman P. Myers The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 1998 746
52. R.J. Reece J.D. Canete W.J. Parsons Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis Arthritis Rheum 42 1999 1481
53. Rep M.H.G. van Oosten B.W. M.T.L. Roos Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting Th1 cells in humans J Clin Invest 99 1997 2225
54. R. Rezzonico D. Burger J.M. Dayer Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines J Biol Chem 273 1998 18720
55. C. Ribbens J.M. Dayer C. Chizzolini CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes Immunology 99 2000 279
56. H. Ruchatz B.P. Leung X.Q. Wei Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen- induced immunopathology J Immunol 160 1998 5654
57. Schellekens G.A. de Jong B.A. van den Hoogen F.H. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 1998 273
58. T.J. Schnitzer D.E. Yocum M. Michalska Subcutaneous administration of CAMPATH-1H: Clinical and biological outcomes J Rheumatol 24 1997 1031
59. M. Sebbag S.L. Parry F.M. Brennan Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis Eur J Immunol 27 1997 624
60. T.J. Smeets R.J. Dolhain F.C. Breedveld Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis J Pathol 186 1998 75
61. J.S. Smolen J.R. Kalden D.L. Scott Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. European Leflunomide Study Group Lancet 353 1999 259
62. C.M. Storgard D.G. Stupack A. Jonczyk Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist J Clin Invest 103 1999 47
63. P.P. Tak F.C. Breedveld Current perspectives on synovitis Arthritis Research 1 1999 11
64. P.P. Tak T.J.M. Smeets M.R. Daha Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity Arthritis Rheum 40 1997 217
65. P.P. Tak P.C. Taylor F.C. Breedveld Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis Arthritis Rheum 39 1996 1077
66. P.C. Taylor A.M. Peters E. Paleolog Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis Arthritis Rheum 43 2000 38
67. P. Tugwell T. Pincus D. Yocum Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group N Engl J Med 333 1995 137
68. Van de Loo F.A. L.A. Joosten van Lent P.L. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis Arthritis Rheum 38 1995 164
69. van der Graaff W.L. A.P. Prins B.A. Dijkmans Prognostic value of Th1/Th2 ratio in rheumatoid arthritis Lancet 351 1998 1931
70. D. Veale G. Yanni S. Rogers Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis Arthritis Rheum 36 1993 893
71. D.J. Veale The role of arthroscopy in early arthritis Clin Exp Rheumatol 17 1999 37
72. R.O. Williams M. Feldmann R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci USA 89 1992 9784
73. P.H. Wooley J. Dutcher M.B. Widmer Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice J Immunol 151 1993 6602
74. D. Xu W.L. Chan B.P. Leung Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells J Exp Med 188 1998 1485
75. D.E. Yocum T cells: Pathogenic cells and therapeutic targets in rheumatoid arthritis Semin Arthritis Rheum 29 1999 27
76. M. Ziolkowska A. Koc G. Luszczykiewicz High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 164 2000 2832